2,5-Piperazinedione,3-hydroxy-1,4-dimethyl-6-[(4-nitro-1H-indol-3-yl)methyl]-3-(phenylmethyl)-,(3R,6S)- (122380-19-2)

Identification
Name:	2,5-Piperazinedione,3-hydroxy-1,4-dimethyl-6-[(4-nitro-1H-indol-3-yl)methyl]-3-(phenylmethyl)-,(3R,6S)-
Synonyms:	2,5-Piperazinedione,3-hydroxy-1,4-dimethyl-6-[(4-nitro-1H-indol-3-yl)methyl]-3-(phenylmethyl)-,(3R-trans)-; Thaxtomin B; Thaxtomine B
CAS:	122380-19-2
Molecular Formula:	C22H22 N4 O5
Molecular Weight:	0
InChI:	InChI=1/C22H22N4O5/c1-24-18(11-15-13-23-16-9-6-10-17(19(15)16)26(30)31)20(27)25(2)22(29,21(24)28)12-14-7-4-3-5-8-14/h3-10,13,18,23,29H,11-12H2,1-2H3/t18-,22+/m0/s1
Molecular Structure:
Properties
Flash Point:	399.9°C
Boiling Point:	737.6°Cat760mmHg
Density:	1.418g/cm³
Refractive index:	1.69
Flash Point:	399.9°C
Safety Data

Other Product

2,5-Piperazinedione,3-hydroxy-3-[(3-hydroxyphenyl)methyl]-1,4-dimethyl-6-[(4-nitro-1H-indol-3-yl)methyl]-,(3R,6S)-
2,5-Piperazinedione,3-[[2-(1,1-dimethylpropyl)-5,7-bis(3-methylbutyl)-1H-indol-3-yl]methyl]-6-methyl-,(3R,6S)-
2,5-Piperazinedione,3-(phenylmethyl)-6-[[(2S,- 9S,9aR)-2,3,9,9a-tetrahydro-9-hydroxy-3- oxo-2-(phenylmethyl)-1H-imidazo[1,2-a]- indol-9-yl]methyl]-,(3S,6S)-
2,5-Piperazinedione,3-[[5-(1,1-dimethyl-2-propenyl)-1H-imidazol-4-yl]methylene]-6-(1-methylethyl)-, (3Z,6S)-
(3R)-3-[[2-(1,3-Benzodioxol-5-ylcarbonyl)-1H-indol-3-yl]Methyl]-1-Methyl-2,5-piperazinedione
2,5-Piperazinedione,3-[[2-(1,1-dimethyl-2-propen-1-yl)-5,7-bis(3-methyl-2-buten-1-yl)-1H-indol-3-yl]methyl]-6-methyl-,(3S,6S)-
2,5-Piperazinedione,3-[[2-(1,1-dimethyl-2- propenyl)-1H-indol-3-yl]methyl]-6-methyl-,(3S,6S)-
2,5-Piperazinedione,3-methyl-6-[[7-(3-methyl-2-buten-1-yl)-1H-indol-3-yl]methyl]-, (3S,6S)-
2,5-Piperazinedione,3-hydroxy-6-methoxy-6-(2-methylpropyl)-3-(phenylmethyl)-, (3R,6S)-rel-(+)-
2,5-Piperazinedione,3-[(1R)-1-[(3R)-2,3-dihydro-3-hydroxy-1-methyl-2-oxo-1H-indol-3-yl]ethyl]-6-[(methylthio)methyl]-,(3S,6R)-
2,5-Piperazinedione,3-[[2-(1,1-dimethylpropyl)-5,7-bis(3-methylbutyl)-1H-indol-3-yl]methyl]-6-methyl-,(3S,6S)-
2,5-Piperazinedione,1,4-dimethyl-3-[(1-methyl-1H-indol-3-yl)methylene]-6-phenyl-, (Z)-
3-[(Z)-[5-[(3,3-Dimethyloxiranyl)methyl]-2-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl]methylene]-6-methylene-2,5-piperazinedione
2,5-Piperazinedione, 3-(1H-indol-3-ylmethyl)-6-(phenylmethyl)-,(3S,6S)-
7,9-Dioxabicyclo[4.2.1]nonane-2-aceticacid,4-(acetyloxy)-3-[(1S,3R,3aS,5R,6R,7R,7aR)-6-(formyloxy)-1-(3-furanyl)octahydro-3a-hydroxy-7-[[(2R,3R)-2-hydroxy-3-methyl-1-oxopentyl]oxy]-7a-methyl-4-methylene-3-[(2R)-2-methyl-1-oxobutoxy]-1H-inden-5-yl]-6-hydroxy-1,3-dimethyl-,methyl ester, (1S,2R,3R,4S,6S)- (9CI)
7,9-Dioxabicyclo[4.2.1]nonane-2-aceticacid,4-(acetyloxy)-3-[(1S,3R,3aS,5R,6R,7R,7aR)-6-(formyloxy)-1-(3-furanyl)octahydro-3a-hydroxy-7-[[(2R,3R)-2-hydroxy-3-methyl-1-oxopentyl]oxy]-7a-methyl-4-methylene-3-(2-methyl-1-oxopropoxy)-1H-inden-5-yl]-6-hydroxy-1,3-dimethyl-,methyl ester, (1S,2R,3R,4S,6S)- (9CI)
(3R,3aR,4R,5R,6R,7aS)-6-[(1S,2R,3R,4S,6S)-4-(acetyloxy)-6-hydroxy-2-(2-methoxy-2-oxoethyl)-1,3-dimethyl-7,9-dioxabicyclo[4.2.1]non-3-yl]-5-(formyloxy)-3-(furan-3-yl)-7a-hydroxy-3a-methyl-7-methylidene-1-oxooctahydro-1H-inden-4-yl (2R,3R)-2-hydroxy-3-methy
7,9-Dioxabicyclo[4.2.1]nonane-2-aceticacid,4-(acetyloxy)-3-[(1S,3R,3aS,5R,6R,7R,7aR)-6-(formyloxy)-1-(3-furanyl)octahydro-3a-hydroxy-7-[[(2R,3R)-2-hydroxy-3-methyl-1-oxopentyl]oxy]-7a-methyl-4-methylene-3-(1-oxopropoxy)-1H-inden-5-yl]-6-hydroxy-1,3-dimethyl-,methyl ester, (1S,2R,3R,4S,6S)- (9CI)
7,9-Dioxabicyclo[4.2.1]nonane-2-aceticacid,4-(acetyloxy)-3-[(1S,3R,3aS,5R,6R,7R,7aR)-3-(acetyloxy)-6-(formyloxy)-1-(3-furanyl)octahydro-3a-hydroxy-7-[[(2R,3R)-2-hydroxy-3-methyl-1-oxopentyl]oxy]-7a-methyl-4-methylene-1H-inden-5-yl]-6-hydroxy-1,3-dimethyl-,methyl ester, (1S,2R,3R,4S,6S)- (9CI)
7,9-Dioxabicyclo[4.2.1]nonane-2-aceticacid,4-(acetyloxy)-3-[(1S,3R,3aS,5R,6R,7R,7aR)-3-(acetyloxy)-6-(formyloxy)-1-(3-furanyl)octahydro-3a-hydroxy-7a-methyl-7-[[(3R)-3-methyl-1,2-dioxopentyl]oxy]-4-methylene-1H-inden-5-yl]-6-hydroxy-1,3-dimethyl-,methyl ester, (1S,2R,3R,4S,6S)- (9CI)